Medtronic has secured FDA approval for its OmniaSecure defibrillation lead to be used in conduction system pacing, the first device cleared for left bundle branch area placement. The small, lumenless ...

The BACKBEAT Global Pivotal Trial, which Orchestra BioMed is actively enrolling as part of a strategic collaboration with Medtronic (NYSE: MDT), targets a similar patient population as MODERATO II ...

Besides the latest additions for its Find X9 series, OPPO also announces the Watch X3 smartwatch and Enco Clip2 earbuds in ...

Johnson & Johnson is introducing an AI-enabled cardiac mapping.  The new Cartosound Sonatamodule integrates with the company’s CARTO System to convert intracardiac echocardiography images into ...

How heart surgeons at Ascension Saint Thomas are helping pioneer a less invasive heart surgery using the latest robot technology.

Cardiovascular diseases (CVDs) remain the leading cause of death worldwide and are now increasingly recognized as conditions with a strong ...

New findings from a DETOUR2 substudy show that minimally invasive percutaneous transmural arterial bypass (PTAB) may offer a ...

Data from the PROMISE III trial suggest that chronic limb-threatening ischemia (CLTI) patients with no other treatment ...